Filter
840
Text search:
chemotherapy
Featured
Recommendations
108
New Publications
209
Language
Document type
No document type
427
Studies & Reports
158
Guidelines
145
Manuals
42
Strategic & Response Plan
30
Fact sheets
15
Training Material
11
Situation Updates
5
Online Courses
4
Brochures
1
Dashboards/Maps
1
Infographics
1
Countries / Regions
India
76
Global
41
Kenya
25
South Africa
19
Ethiopia
18
Western and Central Europe
17
Eastern Europe
15
Africa
14
Ghana
10
Uganda
10
Nepal
10
Zambia
9
Tanzania
9
Bangladesh
9
Malawi
9
Nigeria
8
Philippines
8
Botswana
7
Russia
7
Sierra Leone
6
Rwanda
6
Brazil
6
Venezuela
6
Cambodia
5
Indonesia
5
Ukraine
5
Lesotho
5
Myanmar / Burma
5
Latin America and the Carribbean
5
Syria
4
Mozambique
4
Sudan
4
Namibia
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Zimbabwe
3
South Sudan
3
Middle East and North Africa
3
Burkina Faso
2
Congo, Democratic Republic of
2
Saudi Arabia
2
Cameroon
2
Somalia
2
Pakistan
2
Afghanistan
2
Germany
2
Thailand
2
Argentina
2
Eswatini/ Swaziland
2
Ecuador
2
Libya
2
Angola
2
South–East Asia Region
2
Asia
2
Bhutan
2
Southern Africa
2
Laos
2
Qatar
2
Vietnam
2
Liberia
1
Senegal
1
Haiti
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Gambia
1
Benin
1
Colombia
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Palestine
1
Djibouti
1
Timor Leste/ East Timor
1
Iran
1
Australia
1
Georgia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
290
Clinical Guidelines
156
Public Health
50
Women & Child Health
29
Key Resources
18
Pharmacy & Technologies
10
Capacity Building
9
Toolboxes
TB
142
NTDs
105
AMR
63
COVID-19
37
Pharmacy
31
Caregiver
29
HIV
24
Refugee
17
Rapid Response
15
Planetary Health
12
Mental Health
10
Ebola
9
Polio
9
NCDs
9
Conflict
7
Global Health Education
4
Specific Hazards
3
Disability
2
Cholera
2
Natural Hazards
2
Social Ethics
1
Health Financing Toolbox
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy
...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h
...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint
...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the
...
GUIDE PRATIQUE À L’INTENTION DES PROGRAMMES DE LUTTE CONTRE LES MALADIES TROPICALES NÉGLIGÉES
This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygien
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
